UNVEILING THE ANTIDIABETIC POTENTIAL OF KEMUNING LEAVES (Murraya paniculata L. Jack): AN IN-SILICO EXPLORATION OF DPP-4 INHIBITORY ACTIVITY
Main Article Content
Abstract
Type 2 diabetes mellitus is a global health issue associated with insulin resistance and impaired glucose metabolism. Murraya paniculata L. Jack (kemuning) has shown antidiabetic potential, yet its role as a DPP-4 inhibitor remains underexplored. This study aimed to investigate the potential of kemuning leaf bioactive compounds as natural DPP-4 inhibitors through an in-silico approach. Compound structures were obtained from the PubChem database and analyzed using AutoDock Vina for molecular docking against the DPP-4 protein. Pharmacokinetic properties, toxicity, and drug-likeness were evaluated using pkCSM and SwissADME, while complex stability was assessed through molecular dynamics simulation (RMSF). The results showed that most compounds demonstrated favorable binding affinities (−6.8 to −7.9 kcal/mol), along with acceptable pharmacokinetic and toxicity profiles. Among the tested compounds, 1-aminoindan-1,5-dicarboxylic acid emerged as the most promising candidate for natural DPP-4 inhibition.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
a). Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Attribution-NonCommercial-ShareAlike 4.0 International that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
b). Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
c). Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
References
Antar SA, Ashour NA, Sharaky M, Khattab M, Ashour NA, Zaid RT, Roh EJ, Elkamhawy A, Al-Karmalawy AA (2023) Diabetes mellitus: Classifica-tion, mediators, and complications; A gate to identify potential targets for the development of new effective treatments. Biomedicine & Pharma-cotherapy 168:115734. https://doi.org/10.1016/j.biopha.2023.115734
Arifianti AA (2016) Uji Aktivitas Anti-Diabetes dan Antioksidan Ekstrak Daun Kemuning (Murraya panicula-ta): Metode Penghambatan α-Glukosidase dan DPPH In Vitro. Skripsi, Universitas Negeri Jember
Banerjee P, Kemmler E, Dunkel M, Preiss-ner R (2024) ProTox 3.0: a webserver for the prediction of toxicity of chemi-cals. Nucleic Acids Research 52:W513–W520. https://doi.org/10.1093/nar/gkae303
Elbarbary NS, Ismail EA, El-Hamamsy MH, Ibrahim MZ, Elkholy AA (2024) The DPP-4 inhibitor sitagliptin improves glycaemic control and early-stage di-abetic nephropathy in adolescents with type 1 diabetes using the Min-iMed 780G advanced hybrid closed-loop system: a randomised controlled trial. Diabetologia 67:2637–2649. https://doi.org/10.1007/s00125-024-06265-7
Epelde F (2024) Transforming Diabetes Care: The Expanding Role of DPP-4 Inhibitors in Cardiovascular and Renal Protection. Medicina 60:1793. https://doi.org/10.3390/medicina60111793
Fadlan A, Nusantoro YR (2021) The Effect of Energy Minimization on The Mo-lecular Docking of Acetone-Based Oxindole Derivatives. JKPK 6:69. https://doi.org/10.20961/jkpk.v6i1.45467
Farida Y, Qodriah R, Widyana AP, Zauhara Ifani (2021) Uji Aktivitas Antioksidan, Uji Antikolesterol dan Toksisitas dari Ekstrak Etanol Daun Kemuning. Maj Farmasetika 6:24–31. https://doi.org/10.24198/mfarmasetika.v6i0.
Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, Ostolaza H, Martín C (2020) Pathophysiology of Type 2 Diabetes Mellitus. IJMS 21:6275. https://doi.org/10.3390/ijms21176275
Gautam M, Gupta A, Vijaykumar M, Rao C, Goel R (2012) Studies on the hy-poglycemic effects of Murraya pa-niculata Linn. extract on alloxan-induced oxidative stress in diabetic and non-diabetic models. Asian Pacif-ic Journal of Tropical Disease 2:S186–S191. https://doi.org/10.1016/s2222-1808(12)60149-2
Guanga Ortizo RG, Sharma V, Tsai M-L, Nargotra P, Sun P-P, Chen CW, Dong C-D (2025) Integrating in silico, in vitro, and in situ approaches for characterization of novel peptides from tilapia (Oreochromis niloticus) viscera hydrolysates with dipeptidyl-peptidase IV inhibitory activity. Food Bioscience 63:105619. https://doi.org/10.1016/j.fbio.2024.105619
Hamdi R (2024) Studi In sillico Antidiabetes Senyawa Golongan Flavonoid Ke-muning (Murraya paniculata L.) Ter-hadap PPAR-γ dan Glucose Trans-porter-4. Skripsi, UIN Syarif Hi-dayatullah
Handayani SR, Maharani PT (2019) Uji Ak-tivitas Antidiabetes Infusa Daun Ke-muning (Murraya Paniculata L Jack.) Pada Mencit Putih Jantan Yang Di-induksi Glukosa. Indonesian Journal On Medical Science 6:86–90.
Hossain MdJ, Al‐Mamun Md, Islam MdR (2024) Diabetes mellitus, the fastest growing global public health concern: Early detection should be focused. Health Science Reports 7. https://doi.org/10.1002/hsr2.2004
Khan MAB, Hashim MJ, King JK, Goven-der RD, Mustafa H, Al Kaabi J (2020) Epidemiology of Type 2 Diabetes - Global Burden of Disease and Fore-casted Trends. J Epidemiol Glob Health 10:107–111. https://doi.org/10.2991/jegh.k.191028.001
Komamine M, Kajiyama K, Ishiguro C, Uyama Y (2019) Cardiovascular risks associated with dipeptidyl peptidase‐4 inhibitors monotherapy compared with other antidiabetes drugs in the Japanese population: A nationwide cohort study. Pharmacoepidemiology and Drug 28:1166–1174. https://doi.org/10.1002/pds.4847
Liu H, Guo L, Xing J, Li P, Sang H, Hu X, Du Y, Zhao L, Song R, Gu H (2020) The protective role of DPP4 inhibitors in atherosclerosis. Eur J Pharmacol 875:173037. https://doi.org/10.1016/j.ejphar.2020.173037
Menezes CDA, De Oliveira Garcia FA, De Barros Viana GS, Pinheiro PG, Felipe CFB, De Albuquerque TR, Moreira AC, Santos ES, Cavalcante MR, Garcia TR, Silva TF, Coutinho HDM, De Menezes IRA (2017) Murraya pa-niculata (L.) (Orange Jasmine): Po-tential Nutraceuticals with Ameliora-tive Effect in Alloxan‐Induced Diabet-ic Rats. Phytotherapy Research 31:1747–1756. https://doi.org/10.1002/ptr.5903
Naim MohdJ (2024) A Review of Dipeptidyl Peptidase-4 (DPP-4) and its potential synthetic derivatives in the manage-ment of Diabetes Mellitus. J Angio-therapy 8. https://doi.org/10.25163/angiotherapy.819417
Odion EE, Ambe DA, Akhere M, Odiete EC (2024) Profiling of Semi-polar Sec-ondary Metabolites from the Methanol Leaf of Murraya paniculata (L.) Jack by Chromatographic Technique. Ni-gerian Journal of Pharmaceutical and Biomedical Research 8:1–10
Pires DEV, Blundell TL, Ascher DB (2015) pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Proper-ties Using Graph-Based Signatures. J Med Chem 58:4066–4072. https://doi.org/10.1021/acs.jmedchem.5b00104
Saini K, Sharma S, Khan Y (2023) DPP-4 inhibitors for treating T2DM - hype or hope? an analysis based on the cur-rent literature. Front Mol Biosci 10:1130625. https://doi.org/10.3389/fmolb.2023.1130625
Samyor D, Calderwood D, Carey M, Das AB, Green BD, Deka SC (2022) Di-peptidyl peptidase-4 (DPP-4) inhibito-ry activity and glucagon-like peptide (GLP-1) secretion in arsenically safe pigmented red rice (Oryza sativa L.) and its product. J Food Sci Technol 59:4016–4024. https://doi.org/10.1007/s13197-022-05444-x
Soeatmadji DW, Rosandi R, Saraswati MR, Sibarani RP, Tarigan WO (2023) Clinicodemographic Profile and Out-comes of Type 2 Diabetes Mellitus in the Indonesian Cohort of DISCOVER: A 3-Year Prospective Cohort Study. JAFES 38:68–74. https://doi.org/10.15605/jafes.038.01.10
Wróblewski K, Zalewski M, Kuriata A, Kmiecik S (2025) CABS-flex 3.0: an online tool for simulating protein struc-tural flexibility and peptide modeling. Nucleic Acids Research 53:W95–W101. https://doi.org/10.1093/nar/gkaf412
Zhou B, Rayner AW, Gregg EW, Sheffer KE, Carrillo-Larco RM, Bennett JE. (2024) Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants. The Lancet 404:2077–2093. https://doi.org/10.1016/s0140-6736(24)02317-1
Zhou X-J, Ding L, Liu J-X, Su L-Q, Dong J-J, Liao L (2019) Efficacy and short-term side effects of sitagliptin, vildag-liptin and saxagliptin in Chinese diabe-tes: a randomized clinical trial. Endocr Connect 8:318–325. https://doi.org/10.1530/EC-18-0523
